Asthma is a life-long chronic inflammatory disorder. Eosinophils are major effector cells in this disorder, in great extent due to their production of the eosinophil-derived granule proteins (EDGP), major basic protein (MBP), eosinophil peroxidase (EPO), eosinophil-derived neurotoxin (EDN), eosinophil cationic protein (ECP) and Charcot-Leyden Crystal protein (CLC). However, the mechanisms by which EDGP contribute to airways inflammation are poorly understood. In addition, although stromal cells are known to produce inflammatory cytokines that amplify and contribute to the chronicity of tissue inflammation, their role in asthma has received inadequate attention. We hypothesized that 1) Fibroblasts and other stromal cells are important immune-effector cells in asthma; 2) EDGP are important stimulators of stromal cell cytokine production and 3) EDGP stimulate stromal cell cytokines via definable molecular mechanisms. In testing this hypothesis, we have demonstrated that fibroblasts and epithelial cells are important producers of a wide variety of inflammatory cytokines including interleukin (IL)-6, IL-11, GM-CSF, leukemia inhibitory factor (LIF) and IL-8, provided evidence for dysregulated IL-6, IL-11 and LIF production in late phase asthma and demonstrated that MBP augments IL-1 and TGF-beta-induced cytokine production by fibroblasts and directly stimulates IL-6, LI-11 and GM-CSF production by epithelial cells. We also demonstrated that these effects are associated with proportionate changes in mRNA accumulation and that MBP-induced IL-6 activation is mediated by an NF-IL-6 response element between -158 and -145 in the IL-6 promoter. We propose to further characterize the effects of EDGP on stromal cell cytokine production and define the mechanism and clarify the in vivo relevance of this regulation. We will: I. Characterize the effects of EDGP on fibroblast, epithelial cell and smooth muscle cell immune-effector function. Their ability to regulate the production of IL-6, IL-11, LIF and GM-CSF, alone or in combination, with IL-1 and/or TGF-beta will be characterized. II. Characterize the mechanism by which MBP and other EDGP induce stromal cell cytokine production in vitro. We will characterize: (a) the role of molecular charge in the effects of MBP; (b) the transcriptional and post-transcriptional processes that mediate these effects; and (c) the cis- elements that mediate the effects of EDGP on IL-6 and IL-11 gene transcription. III. Characterize the relationship between MBP and other EDGP, stromal cell cytokines and altered airway physiology in vivo. We will: (a) determine if intratracheal MBP or other EDGP induce IL-6, LIF or GM-CSF production in the mouse airway; (b) determine if cytokine neutralization alters EDGP-induces alterations in airway physiology; and (c) determine if the response element(s) defined in Aim II are operative in vivo using transgenic mice containing EDGp response element-reporter gene constructs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034953-02
Application #
2070247
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1994-01-01
Project End
1998-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Reszka, Krzysztof J; McCormick, Michael L; Buettner, Garry R et al. (2006) Nitric oxide decreases the stability of DMPO spin adducts. Nitric Oxide 15:133-41
Yoon, H J; Zhu, Z; Gwaltney Jr, J M et al. (1999) Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. J Immunol 162:7461-9
Tang, W; Yang, L; Yang, Y C et al. (1998) Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J Biol Chem 273:5506-13
Waxman, A B; Einarsson, O; Seres, T et al. (1998) Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 101:1970-82
Leng, S X; Elias, J A (1997) Interleukin-11 inhibits macrophage interleukin-12 production. J Immunol 159:2161-8
Elias, J A; Wu, Y; Zheng, T et al. (1997) Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol 273:L648-55
Ray, P; Tang, W; Wang, P et al. (1997) Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest 100:2501-11
Zhu, Z; Tang, W; Gwaltney Jr, J M et al. (1997) Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol 273:L814-24
Zhu, Z; Tang, W; Ray, A et al. (1996) Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest 97:421-30
Rochester, C L; Ackerman, S J; Zheng, T et al. (1996) Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 156:4449-56

Showing the most recent 10 out of 15 publications